3 results on '"Dell, Sharon D."'
Search Results
2. Validation of a health-related quality of life instrument for primary ciliary dyskinesia (QOL-PCD).
- Author
-
Behan, Laura, Leigh, Margaret W., Dell, Sharon D., Dunn Galvin, Audrey, Quittner, Alexandra L., and Lucas, Jane S.
- Subjects
CILIARY motility disorders ,QUALITY of life ,PATIENT acceptance of health care ,HEALTH outcome assessment ,MEDICAL screening ,DIAGNOSIS ,COMPARATIVE studies ,DEMOGRAPHY ,EMPLOYMENT ,HEALTH surveys ,RESEARCH methodology ,MEDICAL cooperation ,PSYCHOMETRICS ,QUESTIONNAIRES ,RESEARCH ,RESEARCH evaluation ,RESEARCH funding ,RESPIRATORY diseases ,EVALUATION research ,VITAL capacity (Respiration) ,RESPIRATORY organ abnormalities ,DISEASE complications ,PSYCHOLOGY - Abstract
Background: Quality of life (QOL)-primary ciliary dyskinesia (PCD) is the first disease-specific, health-related QOL instrument for PCD. Psychometric validation of QOL-PCD assesses the performance of this measure in adults, including its reliability, validity and responsiveness to change.Methods: Seventy-two adults (mean (range) age: 33 years (18-79 years); mean (range) FEV1% predicted: 68 (26-115)) with PCD completed the 49-item QOL-PCD and generic QOL measures: Short-Form 36 Health Survey, Sino-Nasal Outcome Test 20 (SNOT-20) and St George Respiratory Questionnaire (SGRQ)-C. Thirty-five participants repeated QOL-PCD 10-14 days later to measure stability or reproducibility of the measure.Results: Multitrait analysis was used to evaluate how the items loaded on 10 hypothesised scales: physical, emotional, role and social functioning, treatment burden, vitality, health perceptions, upper respiratory symptoms, lower respiratory symptoms and ears and hearing symptoms. This analysis of item-to-total correlations led to 9 items being dropped; the validated measure now comprises 40 items. Each scale had excellent internal consistency (Cronbach's α: 0.74 to 0.94). Two-week test-retest demonstrated stability for all scales (intraclass coefficients 0.73 to 0.96). Significant correlations were obtained between QOL-PCD scores and age and FEV1. Strong relationships were also found between QOL-PCD scales and similar constructs on generic questionnaires, for example, lower respiratory symptoms and SGRQ-C (r=0.72, p<0.001), while weak correlations were found between measures of different constructs.Conclusions: QOL-PCD has demonstrated good internal consistency, test-retest reliability, convergent and divergent validity. QOL-PCD offers a promising tool for evaluating new therapies and for measuring symptoms, functioning and QOL during routine care. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
3. Mutations of DNAH11 in patients with primary ciliary dyskinesia with normal ciliary ultrastructure.
- Author
-
Knowles, Michael R., Leigh, Margaret W., Carson, Johnny L., Davis, Stephanie D., Dell, Sharon D., Ferkol, Thomas W., Olivier, Kenneth N., Sagel, Scott D., Rosenfeld, Margaret, Burns, Kimberlie A., Minnix, Susan L., Armstrong, Michael C., Lori, Adriana, Hazucha, Milan J., Loges, Niki T., Olbrich, Heike, Becker-Heck, Anita, Schmidts, Miriam, Werner, Claudius, and Omran, Heymut
- Subjects
MOVEMENT disorders ,ETIOLOGY of diseases ,GENETIC mutation ,ULTRASTRUCTURE (Biology) ,RESPIRATORY diseases ,DELETION mutation ,DIAGNOSIS - Abstract
Rationale Primary ciliary dyskinesia (PCD) is an autosomal recessive, genetically heterogeneous disorder characterised by oto-sino-pulmonary disease and situs abnormalities (Kartagener syndrome) due to abnormal structure and/or function of cilia. Most patients currently recognised to have PCD have ultrastructural defects of cilia; however, some patients have clinical manifestations of PCD and low levels of nasal nitric oxide, but normal ultrastructure, including a few patients with biallelic mutations in dynein axonemal heavy chain 11 (DNAH11). Objectives To test further for mutant DNAH11 as a cause of PCD, DNAH11 was sequenced in patients with a PCD clinical phenotype, but no known genetic aetiology. Methods 82 exons and intron/exon junctions in DNAH11 were sequenced in 163 unrelated patients with a clinical phenotype of PCD, including those with normal ciliary ultrastructure (n=58), defects in outer and/or inner dynein arms (n=76), radial spoke/central pair defects (n=6), and 23 without definitive ultrastructural results, but who had situs inversus (n=17), or bronchiectasis and/or low nasal nitric oxide (n=6). Additionally, DNAH11 was sequenced in 13 subjects with isolated situs abnormalities to see if mutant DNAH11 could cause situs defects without respiratory disease. Results Of the 58 unrelated patients with PCD with normal ultrastructure, 13 (22%) had two (biallelic) mutations in DNAH11; and two patients without ultrastructural analysis had biallelic mutations. All mutations were novel and private. None of the patients with dynein arm or radial spoke/central pair defects, or isolated situs abnormalities, had mutations in DNAH11. Of the 35 identified mutant alleles, 24 (69%) were nonsense, insertion/deletion or loss-of-function splice-site mutations. Conclusions Mutations in DNAH11 are a common cause of PCD in patients without ciliary ultrastructural defects; thus, genetic analysis can be used to ascertain the diagnosis of PCD in this challenging group of patients. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.